P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim resultsBrian Bressler, Dirk Demuth, Manmohan Soni et al.|Journal of Crohn s and Colitis|2018Cited by 4
Clinical Complications, Mortality, and Healthcare Resource Utilization of Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in Ontario, Canada: A Retrospective Cohort StudyL. Lilly, Kevin H.M. Kuo, Chuka Udeze et al.|Advances in Therapy|2025Cited by 1